Abstract:The fabrication and structural identification of mixed ligand chelates resulting from 1-(1H-benzimidazol-2-yl) guanidine (BIG = main ligand) and 1,10-Phenanthroline (phen) (secondary ligand). The tested compounds were investigated using TGA, CHN, spectra analysis (FT-IR, Mass spectra, NMR), melting point, magnetic moments, molar conductance, Ultraviolet–Visible spectroscopy as well computational studies. The conductance results showed that the tested Pd(II), VO(II) and Ag(I) chelates have electrolytes in fresh solutions of DMSO lies in the range 38.12–118.87 Ω −1 cm 2 mol −1 except, Cu(II) chelate is a non-electrolyte it is value equal 15.16 Ω −1 cm 2 mol −1 . FT-IR spectrum displays that the tested main ligand is coordinated with metal ions in a bi-dentate behavior with N, N donor sites of the HN=C and C=N. While the second ligand coordinated with metal ions through its N 2 atom in the pyridine ring. Moreover, the obtained analytical data regarding complexation in solution, molar ratio and continuous variation methods suggest 1M: 1 L molar ratio. Also the stability constant of tested complexes was identified in solution state and the formation constants (Kf) were evaluated by applying continuous-variation method. Stability of complexes was arranged by BIGPAg > BIGPVO > BIGPCu > BIGPPPd in agreement with K f values. The pH profile revealed that the wide range of pH stability of the tested complexes is at pH = 4- 10 in most of them. Magnetic and electronic spectra are applied to deduce the coordinating ability of the tested ligands and the geometric structure of the studied chelates. That data of magnetic susceptibility for ternary mixed chelates are locked to an octahedral geometry for Cu(II) & VO(II) chelates due to the data of (μeff = 1.8 and 1.83 B.M) respectively and Pd(II) and Ag(I) chelates are diamagnetic with square planar and tetrahedral geometry, respectively. The TGA study of these studied complexes displays that the hydrated H 2 O, acetate, nitrate, and acetylacetonate anions are removed in the first (45°C-180°C) and second degradation steps followed directly by degradation of the studied ligands in the following stages. The thermodynamic factors, like ΔS*, ΔH*, E*, A and ΔG* are evaluated from the TGA curves and explained. The DFT/B3LYP computation method was applied for the estimation of the MEP, (HUMO & LUMO) energy for the studied compounds. In-silico assay was executed by two different approaches over compounds to evaluate their biological behavior and degree of interaction with biological systems, before practical application. BIGPPd complex displayed priority in interaction with various protein. In-vitro assay was then carried out for compounds against different microbes and BIGPPd showed high antimicrobial activity with inhibition zones are established to be 45.75 ± 0.10 and 41.95 ± 0.05 mm against B. Cereus and G. Candidum at 25 μg/mL. Also, their cytotoxic behavior was examined against MCF-7, HepG2 and HCT-116 carcinoma cell lines, high cytotoxicity was clearly recorded with BIGPPd complex with IC 50 % are established to be (5, 6.25 and 7.14 μg/mL) respectively. Furthermore, antioxidant activity was examined, and the complexes exhibited high reactivity with trapping free radicals. The BIGPPd exhibited significant free radical scavenging activity with an IC 50 value of 20.15 μg/ml. The interaction of metal chelates with DNA was detected by gel electrophoreses, viscosity and spectral studies. Spectrophotometric titration and viscosity studies expose that each of tested complex is an avid binder to DNA. The intrinsic binding constants were calculated for all the tested compounds could bind to Ct-DNA generally through replacement, intercalative mode & minor groove binding of interactions with the sequence: BIGPVO (6.05×10 4 ) > BIGPCu > BIGPPd> BIGPAg >BIG (1.16×10 3 ). This may be due to enhanced hydrophobic & electrostatic interaction of aromatic rings. Finally, such complexes may be considered as a promising bioactive agent.

DNA interaction, biological, and structural identification studies of bivalent nano‐sized Nickel, Palladium, and Platinum chelates of 2‐(((Z)‐6‐chloro‐3‐((E)‐([2‐hydroxyphenyl]imino)methyl)‐4H‐chromen‐4‐ylidene)amino)phenol Schiff base ligand

Inspecting the Antimicrobial, Bio‐Catalytic, DNA Interactions, In Vitro Cytotoxicity, and Cell Cycle Analysis Efficiency of Newly Nano‐Sized Co (II), Ni (II), Cu (II), and Zn (II) Complexes of Schiff's Base Ligand: Spectroscopic Characterization and Quantum Chemical Calculations

Synthesis of New Nano‐Sized Cu (II), Co (II), and Zn (II) Complexes From β,β′‐Dihydroxy‐Dithioether Derivative: Spectroscopic Characterization, DNA Interactions, in Vitro Cytotoxicity, Cell Cycle Analysis and Quantum Chemical Calculations

New Schiff's base derivative and their nano‐sized Cr (III), Fe (III), Ru (III), and Ir (III) complexes: Preparation, DFT, characterization, bio‐catalytic, DNA interactions, cytotoxicity, and docking studies

Synthesis, characterization of Schiff base metal complexes with 1, 3 propanediamine as secondary chelates and their DNA binding, DNA cleavage, cytotoxicity, antioxidant and activities

Synthesis, Dna/Bsa Binding Studies And In Vitro Biological Assay Of Nickel(Ii) Complexes Incorporating Tridentate Aroylhydrazone And Triphenylphosphine Ligands

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Fabrication, physicochemical characterization and theoretical studies of some new mixed ligands complexes based on N-(1H-benzimidazol-2-yl)-guanidine and 1, 10-phenanthroline: DNA interaction, biological applications and molecular docking approach

Synthesis, Crystal Structure, Biomolecular Interactions and Anticancer Properties of Ni(II), Cu(II) and Zn(II) Complexes Bearing S-allyldithiocarbazate

New Nanosized V(III), Fe(III), and Ni(II) Complexes Comprising Schiff Base and 2-Amino-4-Methyl Pyrimidine: Synthesis, Properties, and Biological Activity

Design, Synthesis, Structural Investigation and Photo Induced Biological Investigations of Co(II), Ni(II) and Cu(II) Complexes Derived from N,O Donor Schiff Bases

Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications

Synthesis, structural investigations, in vitro cytotoxicity, apoptotic activity, cell cycle analysis, and molecular modeling studies of nano‐sized Zn(II) Schiff base complex

A new bio‐active Schiff base ligand and its Ni(II), Cu(II), Ag(I), Zn(II), Cd(II), and La(III) binuclear complexes: synthesis, DFT analysis, antimicrobial, DNA interaction, COXII inhibition, and molecular docking studies

Evaluation of Antimicrobial, Antitumor, Antioxidant Activities, and Molecular Docking Studies of Some Co(II), Cu(II), Mn(II), Ni(II), Pd(II), and Pt(II) Complexes With a Schiff Base Derived From 2‐Chloro‐5‐(trifluoromethyl)aniline

Innovation of some novel complexes based on 1‐(4‐nitrophenyl)‐1H‐1,2,3‐triazol‐4‐yl)methanol ligand: Synthesis, structural elucidation DFT calculation and pharmaceutical studies

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Synthesis, characterization, antimicrobial, molecular docking simulation, and antitumor assays of nanometric complexes based on new thiazole Schiff base derivative

Synthesis, Structural, DFT, In Vitro Biological Exploration, and DNA Interaction of New Ni(II) and Cu(II) Mixed‐Ligand Complexes Featuring 2,2′‐Pyridine‐2,6‐diylbis(1H‐benzimidazole) and 2‐Hydroxy‐naphthaldehyde‐Based Schiff‐Base

New Metal Complexes Incorporating Schiff Base Ligand Based on Pyridine Moiety: Synthesis, Spectral Characterization, DFT, Biological Evaluation, and Molecular Docking

Synthesis of New Naphthyl Aceto Hydrazone-Based Metal Complexes: Micellar Interactions, DNA Binding, Antimicrobial, and Cancer Inhibition Studies